You are required to be logged in to access the full website
Click here if you have forgotten your username or password
28 October 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Wednesday that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug application for Treprostinil-Iloprost SMI, enabling t...
28 October 2026 - Global oncology company Novocure (Nasdaq:NVCR) said on Wednesday that it has entered into a clinical trial collaboration and supply agreement with biopharmaceutical company Verastem Oncology (Nasdaq:VSTM) to evaluate Tumor Treating ...
28 October 2026 - US-based specialty pharmaceutical company US WorldMeds Ventures LLC announced on Tuesday a definitive merger agreement under which it has acquired Orbus Therapeutics Inc, a privately held pharmaceutical company developing investigat...
28 October 2026 - US-based pharmaceutical company DifGen Pharmaceuticals LLC announced on Tuesday the successful completion of the European Decentralised Procedure (DCP) for Tafamidis 61 mg Capsules, marking the company's first major regulatory ...
28 October 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Tuesday that its board of directors has declared a dividend of USD2.52 per share for the fourth quarter of 2026.This amount is unchanged from the previous quarterly divid...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe